Photodynamic generation of reactive oxygen species via light-activated photosensitizer

The process involves administration of a **photosensitizer**, which accumulates in the target tissue (most often a tumor or local vasculature)[6][2][8]. Upon illumination with light of a specific wavelength, the photosensitizer enters an excited electronic state[1][5], then transfers energy to molecular oxygen via intersystem crossing and energy transfer, generating **reactive oxygen species** (especially singlet oxygen)[1][5][7]. These ROS are potent cytotoxins, causing cell death, apoptosis, and/or damage to the vascular wall. In the vascular-targeted variant of PDT, rapid endothelial cell apoptosis and vessel occlusion leads to local infarction of the targeted region[2][4][8]. The specificity and efficacy depend on the photosensitizer used, its localization, light delivery protocol, and timing[2][6][4]. Photosensitizer examples include Photofrin, MV6401, and Tookad[2][4][8]. This method is well-established for the local treatment of solid tumors and sometimes vascular malformations, offering specific spatial and temporal control with well-characterized risks including phototoxicity, non-target tissue damage, and depth limitations.

Other names

ROS-mediated phototoxicityphotodynamic therapy ROS generationPDT-induced vascular occlusion

Light activation of the photosensitizer produces an excited state that transfers energy to molecular oxygen, generating ROS (mainly singlet oxygen), resulting in localized cell damage/apoptosis and/or vascular occlusion[1][5][7][9]